Literature DB >> 15991962

Persistent infection and vascular disease: a systematic review.

J Danesh1, P Appleby.   

Abstract

More than 150 epidemiological or clinical studies have reported on associations between vascular disease and the presence of certain persistent bacterial and viral agents, or of clinical conditions (e.g., periodontal disease) that are associated with persistent infection. This article provides a review of such studies, particularly in relation to Helicobacter pylori, Chlamydia pneumoniae, dental disease and cytomegalovirus (CMV), as well as references to possible mechanisms. The association between coronary heart disease and H. pylori or between heart disease and dental disease may be accounted for by residual confounding. Although markers of C. pneumoniae infection are around twenty times more common in atherosclerotic plaques than in disease-free blood vessels, the sequence of infection and disease is uncertain. For CMV, a limited number of patients with classic atherosclerotic coronary heart disease have been investigated in seroepidemiological studies. For all such agents, better and larger seroepidemiological and pathology-based studies are needed to resolve these uncertainties, as well as - at some stage - large-scale, randomised intervention studies.

Entities:  

Year:  1998        PMID: 15991962     DOI: 10.1517/13543784.7.5.691

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  14 in total

1.  Is Helicobacter pylori a factor in coronary atherosclerosis?

Authors:  J Danesh; J Koreth; L Youngman; R Collins; J R Arnold; Y Balarajan; J McGee; D Roskell
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 2.  Extradigestive manifestations of Helicobacter pylori gastric infection.

Authors:  A Gasbarrini; F Franceschi; A Armuzzi; V Ojetti; M Candelli; E S Torre; A De Lorenzo; M Anti; S Pretolani; G Gasbarrini
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 3.  Microbes, inflammation and atherosclerosis: will old pathology lessons guide new therapies?

Authors:  G M Vercellotti
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

4.  Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study.

Authors:  J Danesh; L Youngman; S Clark; S Parish; R Peto; R Collins
Journal:  BMJ       Date:  1999-10-30

5.  Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; Y Wong; M Bernardes-Silva; M Ward
Journal:  BMJ       Date:  2000-07-22

6.  Relation between number of siblings and adult mortality and stroke risk: 25 year follow up of men in the Collaborative study.

Authors:  C L Hart; G Davey Smith
Journal:  J Epidemiol Community Health       Date:  2003-05       Impact factor: 3.710

7.  Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease.

Authors:  J Danesh; Y Wong; M Ward; J Muir
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

8.  Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk.

Authors:  W James Waldman; Marshall V Williams; Stanley Lemeshow; Philip Binkley; Denis Guttridge; Janice K Kiecolt-Glaser; Deborah A Knight; Katherine J Ladner; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2007-09-12       Impact factor: 7.217

9.  Periodontal disease: The sixth complication of diabetes.

Authors:  Rajiv Saini; Santosh Saini; Rs Sugandha
Journal:  J Family Community Med       Date:  2011-01

10.  Evidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events.

Authors:  Philip F Binkley; Glen E Cooke; Amanda Lesinski; Mackenzie Taylor; Min Chen; Bryon Laskowski; W James Waldman; Maria E Ariza; Marshall V Williams; Deborah A Knight; Ronald Glaser
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.